The Payer Exchange

E13: USA - Matt Harman

Continuing the US-focused series, Omar Ali speaks with Matt Harman, VP of Clinical Solutions at Employers Health, bringing an employer-sponsored health plan perspective t

E12: USA - Drake Reiter

In Episode 12, Omar Ali speaks with Drake Reiter, Director of Pharmacy Operations at Priority Health, about how a regional US health plan is thinking about the next phase

E11: USA - Jill Hanson

Launching Series 3 of The Payer Exchange’s special US focus, Omar Ali speaks with Jill Hanson, VP of Regional Pharmacy at Centene Pharmacy Services, who brings a specialt

Season 3 Trailer: USA Special

What happens when the world’s largest pharmaceutical market fundamentally changes the way it pays for medicines? As US policy evolves around Most Favoured Nation pricing

E10: Saudi Arabia - Abdulrazag Al-Jazairi

In the final episode of the series, Omar speaks with Dr Abdulrazag Al-Jazairi, Advisor to the Saudi Food and Drug Authority, about the rapidly evolving payer and HTA envi

E6: UK - Yousaf Ahmad

In this opening episode, Omar Ali is joined by Dr Yousaf Ahmad, Chief Pharmacist and Director of Medicines Optimisation at a NHS Integrated Care System. They explore the

E7: Poland - Krzysztof Łanda

Omar speaks with Dr Krzysztof Łanda, former Deputy Minister of Health, health economist, and someone who’s helped shape the pricing and HTA landscape in Poland over the p

E8: Canada - Don Husereau

In this episode, Omar speaks with Canadian health economist and policy advisor Don Husereau about Canada’s unique payer landscape. Don isn’t your typical policy analyst.

E9: Belgium - Lieven Annemans

Omar is joined by Professor Lieven Annemans, former chair of Belgium’s health economics advisory committee, to explore the complexities of European HTA policy. They talk

Series 2 Trailer

What happens when the world’s pricing pressures start reshaping national systems from the inside? In Season 2 of The Payer Exchange, we speak to former payers and policy

E5: Spain - Jaime Espín

In this final episode of our first series, I speak with Jaime Espín—health economist, former adviser to the Spanish Ministry of Health, and one of the country’s most reco

E4: Netherlands - Hans Serverens

In this episode, I speak with Hans Severens, former Vice Chair of the Dutch Health Council and a key figure in health technology assessment at ZIN in the Netherlands. We

E3: Italy - Fabrizio Gianfrate

In this episode, I’m joined by Professor Fabrizio Gianfrate, a voting member of AIFA—the Italian Medicines Agency—and a long-time figure in European health economics. We

E2: Germany - Detlev Parow

In this episode, I speak with Detlev Parow, a former payer from one of Germany’s largest statutory health insurance funds. We unpack how German systems are managing acces

E1: France - Jean-Claude Castanier

In our first episode, I’m joined by Jean Claude Castanier, a former CEPS member and leading voice in France’s pricing and reimbursement landscape. We talk about the ongoi

Series 1 Trailer

What really shapes access decisions in healthcare? Beyond the policy documents and headlines—it’s the people. The payers making the calls. I’m Omar Ali, and The Payer Ex